ABOUT THIS DESK
What aminopeptides.net Is
A calm, encyclopedic reference shelf — honest about what the research does and does not show.
What this reference shelf is
aminopeptides.net is a reference shelf for the published research on compounds studied in metabolic and cellular-aging research. The current scope holds three entries: semaglutide, MOTS-c, and NAD+.
This is not a store. It sells no compounds, supplements, or services. It runs no clinic and keeps no prescriber. It recommends no doses or protocols. The content is a curated reading of peer-reviewed science, set out in plain language, with numbered citations tied to a full references list.
It carries no affiliation with any manufacturer, compounding pharmacy, academic institution, or healthcare provider. Nothing here answers to an advertiser, a sponsor, or a commercial relationship — the reading is shaped by the literature alone.
How entries are written
Every factual claim on the shelf rests on a citation from the peer-reviewed literature or, for regulatory and compliance status, on official sources such as FDA labeling. Citations are numbered in-text (as [N]) and resolve to their full reference on the references page.
For each compound, the entry sets out:
- What the compound is and where it comes from
- Its best-characterized mechanism, drawn from published research
- What specific studies found, with the species studied and the outcome measured
- Community-reported experience, marked "anecdotal, not clinical evidence" wherever it appears
- Safety and regulatory detail from the clinical literature and official sources
Where the evidence is thin, single-lab, or preclinical only, the text says so plainly. Where human data are observational rather than interventional, that line is drawn. Animal findings are never dressed as human findings, and preliminary evidence is never presented as settled fact. The aim is an accurate map of the literature — gaps and all.
Scope and its limits
The shelf covers the metabolic-and-cellular-aging angle on its three member compounds. It is no exhaustive compendium of everything published on any of them — semaglutide alone has produced thousands of papers. What it selects are the well-powered or methodologically significant studies, the key reviews, and the foundational mechanistic work.
Entries are refreshed as the literature moves, but any reading of the literature is a snapshot by nature. Readers with clinical, research, or regulatory questions should go to primary sources, licensed healthcare providers, and official regulatory databases (FDA.gov, PubMed.gov).
No individual author credentials appear, because this is a reference shelf, not a personal blog. Staging fake authors, fake affiliations, or fake addresses would mislead, and the shelf does not do it. What it does show is a traceable citation behind every factual claim — more useful than a credential in any case.